Search research articles
Contact Us
Filters
Showing results (81-90 of 242) with videos related to
Page
of 25
Sort By:
Plos One
|
May 13, 2015
Clinical Outcome among Nasopharyngeal Cancer Patients in a Multi-Ethnic Society in Singapore
Han Wen Mak, Shan Hui Lee, Jeremy Chee, et al.
Head & Neck
|
February 17, 2018
Time course and clinical characterization of cisplatin-induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian population
Sze Ling Chan, Li Shia Ng, Xueying Goh, et al.
Cancer Chemotherapy and Pharmacology
|
October 3, 2007
A phase I study of docetaxel with ketoconazole modulation in patients with advanced cancers
Wei-Peng Yong, Ling-Zhi Wang, Lai-San Tham, et al.
Medicinal Research Reviews
|
December 8, 2020
The pleiotropic role of transcription factor STAT3 in oncogenesis and its targeting through natural products for cancer prevention and therapy
Manoj Garg, Muthu K Shanmugam, Vipul Bhardwaj, et al.
Neuroscience Letters
|
September 26, 2006
Effects of high dose of simvastatin on levels of dopamine and its reuptake in prefrontal cortex and striatum among SD rats
Qing Wang, Xian Nan Tang, Lingzhi Wang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 18, 2004
Tailoring distant metastatic imaging for patients with clinically localized undifferentiated nasopharyngeal carcinoma
Mahesh B Kumar, Jiade Jay Lu, Kwok Seng Loh, et al.
Translational Lung Cancer Research
|
September 29, 2021
Interactions between epidermal growth factor receptor tyrosine kinase inhibitors and proton-pump inhibitors/histamine type-2 receptor antagonists in non-small cell lung cancer: a systematic review and meta-analysis
Wilson Sim, Sneha Rajiv Jain, Wen Hui Lim, et al.
International Journal of Cancer
|
September 25, 2021
Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patients
Yiqing Huang, Yu Yang Soon, Folefac Aminkeng, et al.
Frontiers in Oncology
|
April 26, 2021
Characterization and Establishment of a Novel EBV Strain Simultaneously Associated With Nasopharyngeal Carcinoma and B-Cell Lymphoma
Fenggang Yu, Nicholas L Syn, Yanan Lu, et al.
Therapeutic Drug Monitoring
|
April 22, 2006
Ketoconazole renders poor CYP3A phenotype status with midazolam as probe drug
Lai-San Tham, How-Sung Lee, Lingzhi Wang, et al.
Page
of 25
Search research articles
Search
Showing results (81-90 of 242) with videos related to
Sort By:
Page
of 25
Plos One
|
May 13, 2015
Clinical Outcome among Nasopharyngeal Cancer Patients in a Multi-Ethnic Society in Singapore
Han Wen Mak, Shan Hui Lee, Jeremy Chee, et al.
Head & Neck
|
February 17, 2018
Time course and clinical characterization of cisplatin-induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian population
Sze Ling Chan, Li Shia Ng, Xueying Goh, et al.
Cancer Chemotherapy and Pharmacology
|
October 3, 2007
A phase I study of docetaxel with ketoconazole modulation in patients with advanced cancers
Wei-Peng Yong, Ling-Zhi Wang, Lai-San Tham, et al.
Medicinal Research Reviews
|
December 8, 2020
The pleiotropic role of transcription factor STAT3 in oncogenesis and its targeting through natural products for cancer prevention and therapy
Manoj Garg, Muthu K Shanmugam, Vipul Bhardwaj, et al.
Neuroscience Letters
|
September 26, 2006
Effects of high dose of simvastatin on levels of dopamine and its reuptake in prefrontal cortex and striatum among SD rats
Qing Wang, Xian Nan Tang, Lingzhi Wang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 18, 2004
Tailoring distant metastatic imaging for patients with clinically localized undifferentiated nasopharyngeal carcinoma
Mahesh B Kumar, Jiade Jay Lu, Kwok Seng Loh, et al.
Translational Lung Cancer Research
|
September 29, 2021
Interactions between epidermal growth factor receptor tyrosine kinase inhibitors and proton-pump inhibitors/histamine type-2 receptor antagonists in non-small cell lung cancer: a systematic review and meta-analysis
Wilson Sim, Sneha Rajiv Jain, Wen Hui Lim, et al.
International Journal of Cancer
|
September 25, 2021
Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patients
Yiqing Huang, Yu Yang Soon, Folefac Aminkeng, et al.
Frontiers in Oncology
|
April 26, 2021
Characterization and Establishment of a Novel EBV Strain Simultaneously Associated With Nasopharyngeal Carcinoma and B-Cell Lymphoma
Fenggang Yu, Nicholas L Syn, Yanan Lu, et al.
Therapeutic Drug Monitoring
|
April 22, 2006
Ketoconazole renders poor CYP3A phenotype status with midazolam as probe drug
Lai-San Tham, How-Sung Lee, Lingzhi Wang, et al.
Page
of 25